Neovascular glaucoma or rubeosis iridis developed in five eyes (83%).
有五个病例(83%)发生新生血管性青光眼或虹膜新生血管。
Neovascular glaucoma or rubeosis iridis developed in five eyes (83%).
有五个病例(83%)发生新生血管性青光眼或虹膜新生血管。
Combined trabeculotomy-trabeculectomy may offer the best chance of success in late onset congenital glaucoma.
本文认为小梁网切开术合并切除术对处理晚发型先天性青光眼可提供更好手术成功机会。
Objective To research the efficacy of treating absolute glaucoma by deep layer sclera strap insertion combined with cycloanemization.
探讨深层巩膜条带嵌置联合睫状体贫血术治疗绝对期青光眼效果。
The causes leading to blindness and low vision were cataract, ceratonosus, glaucoma and ocular fundus Disease, etc.
致盲和致低视力眼病均以白居首位,其次为角膜病、青光眼、眼底病等。
Clinical manifestation with unilateral glaucoma, corectopia, ectropion uvea, peripheral anterior synechiae (PAS) and characterized by pigmented nodules on the iris.
临床表徵除了瞳孔偏向,葡萄膜外翻,周边连黏,青光眼之外还具有特殊色素性节结在虹彩表面。
To discuss the opportunity,method and complication of re operation to treat flat anterior chamber with hypotony after filtering s urgery of glaucoma.
探讨因抗青光眼外引流手术后低眼压性浅前房或无前房(下称浅前房)再手术时机、手术方法及术后并发症。
The authors suggest that goniotomy may benefit selected patients with idiopathic uveitic glaucoma or that associated with juvenile rheumatoid arthritis, sarcoidosis, or cataract surgery.
作者建议,对先天性、或与幼年风湿性关节炎、类肉瘤病、或白手术有关葡萄膜性青光眼患者,前房角切开术有效。
Objective To evaluate the efficacy of Cyclocryotherapy combined with retrobulbar injection of dehydrated alcohol in treating late neovascular glaucoma patients,that released their distress.
观察睫状体冷凝术联合球后无水酒精注射治疗新生血管性青光眼患者眼痛等临床症状疗效。
Methods Cyclocryotherapy was performed on the patients with late-stage glaucoma,whose intraocular pressure (IOP) could not be controlled by medicine and was unsuitable for filtering operation.
方法对药物不能控制眼压,且不适宜施行滤过手术青光眼,进行睫状体冷凝手术,并以药物辅助治疗。
Conclusion: Condensation to partial ciliary body and the whole retina plus second-stage trabeculectomy is one of so effective methods in the treatment of neoformative vascular glaucoma.
部分睫状体和全视网膜冷凝加二期小梁切除术是治疗新生血管性青光眼有效方法。
声明:以例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达容亦不代表本软件观点;若发现问题,欢迎向我们指正。